Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study
1999
Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies
2006
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
2002
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Risk Factors and Predictors of Outcome in Patients with Cancer and Breakthrough Candidemia
2001
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
2012 Standout
Clinical Epidemiology of Stenotrophomonas maltophilia Colonization and Infection
2002
Viridans Group Streptococcal Infections Among Children With Cancer and the Importance of Emerging Antibiotic Resistance
2006
Candidemia in a Tertiary Care Cancer Center
2003
Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres
2005
Current Trends in the Epidemiology of Nosocomial Bloodstream Infections in Patients with Hematological Malignancies and Solid Neoplasms in Hospitals in the United States
2003
Review of the Incidence and Prognosis of Pseudomonas aeruginosa Infections in Cancer Patients in the 1990s
2000
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
2007 Standout
In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model
2002
Infective Endocarditis Due to Penicillin-Resistant Viridans Group Streptococci
2007
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Candida lusitaniae: A Cause of Breakthrough Fungemia in Cancer Patients
2001
Epidemiological Investigation of Fluoroquinolone Resistance in Infections Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coliandKlebsiella pneumoniae
2001
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
2003
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Glucocorticoids and invasive fungal infections
2003
Echinocandin antifungal drugs
2003 Standout
The central nervous system and infection by Candida species
2000
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Infections due to emerging and uncommon medically important fungal pathogens
2004
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment
2004
Methicillin-Resistant Staphylococcal Bacteremia in Patients with Hematologic Malignancies: Clinical and Microbiological Retrospective Comparative Analysis ofS. haemolyticus, S. epidermidisandS. aureus
2004
GRADE guidelines 6. Rating the quality of evidence—imprecision
2011 Standout
Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study
2006 Standout
Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact
2006
Epidemiology, treatment and outcome of candidemia: a five‐year review at three Canadian hospitals
2002
The role of nasal carriage in Staphylococcus aureus infections
2005 Standout
Trends in species causing fungaemia in a tertiary care medical centre over 12 years
2001
Two Cases of Fungemia due to Candida lusitaniae and a Literature Review
2002
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
2002
Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole
2000
Possible Role of Catheters in Saccharomyces boulardii Fungemia
2000
Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci
2006
Immunity to fungal infections
2011 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Candida lusitaniaeInfections in the Era of Fluconazole Availability
2003
Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes
2011
-D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
2004
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
2004 Standout
Antifungal agents: mechanisms of action
2003 Standout
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Emerging and less common fungal pathogens
2002
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Antimicrobial Susceptibility Patterns among Viridans Group Streptococcal Isolates from Infective Endocarditis Patients from 1971 to 1986 and 1994 to 2002
2004
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Candida Infections of Medical Devices
2004 Standout
Antifungal Activities of Antineoplastic Agents:Saccharomyces cerevisiaeas a Model System To Study Drug Action
1999
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
2005
Antifungal Susceptibility ofCandidaBiofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins
2002
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
2012
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Invasive Candidiasis
2015 Standout
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
2005 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Development of an Immunochromatographic Strip for Simple Detection of Penicillin-Binding Protein 2′
2010 StandoutNobel
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Reappraisal With Meta-Analysis of the Addition of Gram-Positive Prophylaxis to Fluoroquinolone in Neutropenic Patients
2003
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Prosthetic Joint Infection
2014 Standout
Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002
2004
Guidelines for Treatment of Candidiasis
2004 Standout
Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
2005
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Comparison of Biofilms Formed byCandidaalbicansandCandidaparapsilosison Bioprosthetic Surfaces
2002
Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center.
2005
Multiple Antibiotic Resistance in Stenotrophomonas maltophilia : Involvement of a Multidrug Efflux System
2000
Works of A. Kunová being referenced
Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol
1999
Bacteremia Due to Multiresistant Gram-Negative Bacilli in Neutropenic Cancer Patients: A Case Controlled Study
1998
Fungemia in Cancer Patients Undergoing Chemotherapy Versus Surgery: Risk Factors, Etiology and Outcome
1997
Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive bacteriemia
1998
Breakthrough Fungemia Appearing during Empiric Therapy with Amphotericin B
1997
Nosocomial candidaemias due to species other than Candida albicans in cancer patients
1999
Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes
1998
<i>Candida</i><i>glabrata</i>, <i>Candida</i><i>krusei</i>, Non-albicans <i>Candida</i> spp., and Other Fungal Organisms in a Sixty-Bed National Cancer Center in 1989-1993: No Association with the Use of Fluconazole
1995
Eight-Year Surveillance of Non-Albicans Candida spp . in an Oncology Department Prior to and After Fluconazole Had Been Introduced into Antifungal Prophylaxis
1997
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome
1998
Viridans Streptococcal Bacteraemia Due to Penicillin-Resistant and Penicillin-Sensitive Streptococci: Analysis of Risk Factors and Outcome in 60 Patients from a Single Cancer Centre Before and After Penicillin is Used for Prophylaxis
1997
Fungaemia due to Fusarium spp. in cancer patients
1997
Bacteremia and Fungemia in Pediatric Versus Adult Cancer Patients after Chemotherapy: Comparison of Etiology, Risk Factors and Outcome
1998
NosocomialCandida kruseiFungemia in Cancer Patients: Report of 10 Cases and Review
1999
Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia.
1996
Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
1996
Invasive infections due toClavispora lusitaniae
1999
Bacteremia Due to CiprofLoxacin-Resistant Pseudomonas Aeruginosain Cancer Patients: Risk Factors for Resistance and Outcome of 25 Episodes. A Case-Control Study
1999
Bacteremia in neutropenic versus nonneutropenic cancer patients: etiology and outcome in 401 episodes.
1997